New Zealand Clinical Research (NZCR) is putting put out a call for healthy males in Auckland and Christchurch to be part of two large trials researching potential new treatments for breast cancer.

A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab
biosimilar, in healthy adult subjects

NZCR is reducing medical waste and helping the Pacific Islands at the same time

NZCR staff received a lovely surprise this week.

Alvotech receives EU approval for AVT02

NZCR- AKL has opened their new outpatient facility today.

NZCR Supports Covid -19 Vaccination for all New Zealanders.

Lipid and Diabetes Research Group joins the NZCR research family

Drs Christian Schwabe and Dr Chris Wynne are authors of a recent Bevacizumab biosimilar publication.

NZCR CEO receives IQVIA Certificate of Achievement (2020)

Kiwis are being given an opportunity to take part in a trial of a potential new COVID-19 vaccine.

New Zealand is leading the world in a new era of exciting gene research with potential to cure genetic conditions in the future.

Get in touch today

NZCR Advancing global health